Sonnet Biotherapeutics Holdings Inc (SONN) — Long-term Investment Intensity

Latest as of March 2020: 1.2%

Sonnet Biotherapeutics Holdings Inc (SONN) has a Long-term Investment Intensity of 1.2% as of March 2020. Long-term investments of $389.60K represent 1.2% of total assets of $31.32 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Check Sonnet Biotherapeutics Holdings Inc liquid asset ratio to evaluate the company's liquid asset resilience ratio.

LT Investment Intensity

1.2%
LT Investments / Total Assets

Long-term Investments

$389.60K
USD

Total Assets

$31.32 Million
USD

Country

USA
NASDAQ

Sonnet Biotherapeutics Holdings Inc Long-term Investment Intensity (2013–2016)

This chart shows how Sonnet Biotherapeutics Holdings Inc's Long-term Investment Intensity has evolved across 4 annual periods from 2013 to 2016. As of March 2020, the intensity stands at 1.2%, reflecting long-term investments of $389.60K against total assets of $31.32 Million USD. For the complete balance sheet picture, see SONN total asset value.

Annual Long-term Investment Intensity for Sonnet Biotherapeutics Holdings Inc (2013–2016)

The table below presents the year-by-year Long-term Investment Intensity for Sonnet Biotherapeutics Holdings Inc from 2013 to 2016, covering 4 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. Read Sonnet Biotherapeutics Holdings Inc (SONN) financial obligations for a breakdown of total debt and financial obligations.

Year LT Investment Intensity LT Investments (USD) Total Assets Change (pp)
2016 2.4% $800.00K $33.49 Million ▼ -0.2 pp
2015 2.6% $1.08 Million $42.21 Million ▼ -1.9 pp
2015 4.4% $1.59 Million $35.79 Million ▼ -8.0 pp
2013 12.4% $2.49 Million $20.09 Million
pp = percentage points